Innocenti, F., Wang, J., Sibley, A., Jiang, C., Etheridge, A., Shen, F., … Quintanilha, J. (2020). Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients. European Journal of Cancer, 138, S9–S10. https://doi.org/10.1016/S0959-8049(20)31090-X

Innocenti, F., J. Wang, A. Sibley, C. Jiang, A. Etheridge, F. Shen, J. Patel, et al. “Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients.” European Journal of Cancer 138 (October 1, 2020): S9–10. https://doi.org/10.1016/S0959-8049(20)31090-X.

Innocenti F, Wang J, Sibley A, Jiang C, Etheridge A, Shen F, et al. Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients. European Journal of Cancer. 2020 Oct 1;138:S9–10.

Innocenti, F., et al. “Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients.” European Journal of Cancer, vol. 138, Oct. 2020, pp. S9–10. Scopus, doi:10.1016/S0959-8049(20)31090-X.

Innocenti F, Wang J, Sibley A, Jiang C, Etheridge A, Shen F, Patel J, Daniel H, Dees E, Howard M, Bertagnolli M, Rugo H, Kindler H, Kelly W, Ratain M, Kroetz D, Owzar K, Schneider B, Lin D, Quintanilha J. Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients. European Journal of Cancer. 2020 Oct 1;138:S9–S10.